Guided Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2012 | -1.3% | -128.3% | -130.4% |
| FY2013 | -30.7% | -805.6% | -879.9% |
| FY2014 | -204.6% | -13,336.9% | -15,204.6% |
| FY2015 | 64.3% | -14,826.2% | -16,433.3% |
| FY2017 | -117.2% | -1,279.1% | -4,383.6% |
| FY2018 | -56.1% | -2,715.8% | 1,782.5% |
| FY2019 | -94.4% | -2,602.8% | -5,336.1% |
| FY2020 | 140.2% | -1,031.4% | -273.5% |
| FY2021 | 24.7% | -2,916.0% | -2,555.6% |
| FY2022 | -523.1% | -25,638.5% | -33,392.3% |
| FY2023 | 36.7% | -3,527.6% | -3,560.2% |
| FY2024 | 28.6% | -30,114.3% | -34,528.6% |
| FY2025 | 74.4% | -309.3% | -416.7% |